Garmin Ltd. · GRMN · FY2026 Q2 · Calendar Q3 2026
Garmin raises 2026 outlook as wearables and marine drive Q2
Garmin's Q2 evidence supports a constructive growth case: record revenue, margin expansion, stronger FY2026 guidance, and continued fitness, marine, and product-launch momentum. The case is tempered by cost pressure, a non-recurring tariff refund, weaker near-term auto OEM revenue, and execution dependence on future products and the 2027 Mercedes-Benz program.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about GRMN FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, management moved from maintained to raised FY2026 guidance. Q2 also added evidence of higher-margin product momentum, the Training Peaks and TrainHeroic acquisitions, and a Thailand manufacturing facility, while highlighting memory-chip costs and H2 auto OEM weakness.
Guidance delta
Management raised FY2026 guidance to $8.05 billion of revenue and $10 EPS from the prior quarter's maintained outlook.
Key takeaways
- Q2 record revenue and margin expansion were led by fitness, marine, and favorable product mix.
- Fitness remains the primary growth engine, with service revenue and new products supporting the strategy.
- Higher memory-chip costs, softer auto OEM revenue, and the non-recurring tariff refund are key offsets.
Management priorities
- Launch products across wearables, aviation, and marine.
- Complete the Thailand facility and ramp it up in early 2027.
- Expand service revenue and Connect Plus while integrating Training Peaks and TrainHeroic.
- Prepare for the Mercedes-Benz auto OEM program in 2027.
Follow GRMN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Tigress Financial | Strong Buy | Strong Buy | Maintain | Aug 6, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Apr 16, 2026 |
| Longbow Research | Buy | Neutral | Upgrade | Dec 3, 2025 |
| B of A Securities | Underperform | Neutral | Downgrade | May 22, 2024 |
| Barrington Research | Equal Weight | Equal Weight | Maintain | Feb 22, 2024 |
| Keybanc | Equal Weight | Sector Weight | Maintain | Apr 19, 2023 |
| Deutsche Bank | Buy | Hold | Upgrade | Jan 5, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 29, 2021 |
| CFRA | Hold | Hold | Maintain | Apr 29, 2020 |
| Baird | Neutral | Neutral | Maintain | Feb 22, 2018 |
| Goldman Sachs | Neutral | Sell | Upgrade | Mar 6, 2017 |
| Raymond James | Market Perform | Outperform | Downgrade | Aug 22, 2016 |
| Bank of America | Underperform | Buy | Downgrade | Aug 4, 2016 |
| Citigroup | Neutral | Sell | Upgrade | Oct 29, 2015 |
| Dougherty & Co. | Neutral | Buy | Downgrade | Oct 15, 2015 |
| Dougherty | Neutral | Buy | Downgrade | Oct 15, 2015 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 28, 2015 |
| DA Davidson | Neutral | Neutral | Maintain | Sep 14, 2015 |
| Oppenheimer | Market Perform | Outperform | Downgrade | Mar 16, 2015 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Feb 20, 2015 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Jan 26, 2015 |
| Pacific Crest | Sector Perform | Underperform | Upgrade | Jan 14, 2015 |
| Wells Fargo | Market Perform | Outperform | Downgrade | Feb 20, 2014 |
| Midtown Partners | Neutral | Neutral | Maintain | Nov 1, 2013 |
| William Blair | Outperform | Outperform | Maintain | Feb 15, 2013 |
| Wedbush | Outperform | Neutral | Upgrade | Aug 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $280.31. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $370 | $301.94 | +32.0% | Aug 6, 2026 |
| Morgan Stanley | Analyst unavailable | $289 | $291.65 | +3.1% | Jul 30, 2026 |
| Barclays | Tim Long | $297 | $294.83 | +6.0% | Jul 30, 2026 |
| Tigress Financial | Analyst unavailable | $325 | $237.45 | +15.9% | May 20, 2026 |
| Morgan Stanley | Analyst unavailable | $249 | $250.6 | -11.2% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $238 | $253.08 | -15.1% | Apr 30, 2026 |
| Tigress Financial | Analyst unavailable | $320 | $242.46 | +14.2% | Feb 20, 2026 |
| Barclays | Analyst unavailable | $240 | $237.46 | -14.4% | Feb 19, 2026 |
| Morgan Stanley | Erik Woodring | $252 | $237.46 | -10.1% | Feb 19, 2026 |
| Barclays | Analyst unavailable | $217 | $212.6 | -22.6% | Jan 16, 2026 |
| Tigress Financial | Analyst unavailable | $310 | $202.74 | +10.6% | Dec 19, 2025 |
| Barclays | Analyst unavailable | $208 | $219.61 | -25.8% | Oct 30, 2025 |
| Tigress Financial | Ivan Feinseth | $305 | $245.53 | +8.8% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $193 | $236.05 | -31.1% | Sep 19, 2025 |
| Tigress Financial | Ivan Feinseth | $215 | $171.76 | -23.3% | Sep 19, 2024 |
| Barclays | Tim Long | $133 | $182.76 | -52.6% | Sep 13, 2024 |
| Tigress Financial | Ivan Feinseth | $210 | $170.18 | -25.1% | May 14, 2024 |
| Tigress Financial | Analyst unavailable | $165 | $97.6 | -41.1% | Aug 5, 2022 |
| Morgan Stanley | Analyst unavailable | $96 | $96.57 | -65.8% | Jul 28, 2022 |
| Morgan Stanley | Erik Woodring | $115 | $96.72 | -59.0% | Jun 14, 2022 |
| Tigress Financial | Ivan Feinseth | $208 | $106.03 | -25.8% | May 6, 2022 |
| Deutsche Bank | Jeffrey Rand | $150 | $109.74 | -46.5% | Apr 30, 2022 |
| Bank of America Securities | Ronald Epstein | $140 | $119.61 | -50.1% | Mar 18, 2022 |
| Tigress Financial | Ivan Feinseth | $205 | $110.44 | -26.9% | Feb 28, 2022 |
Track every rating change on GRMN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationGarmin Ltd. specializes in the design, development, manufacturing, marketing, and global distribution of diverse wireless products and solutions. Its operations span across North and South America, the Asia Pacific region, the Australian Continent, Europe, the Middle East, and Africa. The company's offerings are organized into several key segments: Fitness: This division caters to athletes and active individuals with products like specialized running and multi-sport watches, cycling computers, activity trackers, smartwatches, and various fitness-related accessories. Additionally, it supports these offerings with its Garmin Connect web and mobile platforms, alongside Connect IQ, an ecosystem for app development. Outdoor: Garmin's Outdoor category features rugged adventure watches, portable GPS devices, golf-specific instruments and accompanying mobile applications, plus specialized dog tracking and training systems.…
Historical context
All GRMN earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
| SAIL SailPoint, Inc. | FY2027 Q2 · Calendar Q3 2026 | +13.8% | -1.2% | SailPoint pairs 25% ARR growth with accelerating AI-driven adoption |
| CIEN Ciena Corporation | FY2026 Q3 · Calendar Q3 2026 | +22.0% | -10.4% | Ciena raises outlook as AI networking demand lifts backlog |
| DOCU DocuSign, Inc. | FY2027 Q2 · Calendar Q3 2026 | +6.4% | +3.7% | DocuSign Q2 FY27: IAM momentum supports a raised outlook |
| IOT Samsara Inc. | FY2027 Q2 · Calendar Q3 2026 | +25.0% | +3.7% | Samsara: AI adoption expands as FY27 guidance holds |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the GRMN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-13T21:15:14.389999+00:00
- FN2 earnings calendar · 2026-09-03T01:23:14.877038+00:00
- Polygon adjusted daily market bars · 2026-09-22T03:00:51.856974+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-22T03:00:51.854208+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.